Walleye Trading
CMPX icon

Walleye Trading’s Compass Therapeutics CMPX Stock Holding History

Walleye Trading’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.8K Hold
25,000
– – ﹤0.01% 3569
2026
Q1 		$132K Hold
25,000
– – ﹤0.01% 3329
2025
Q4 		$134K Hold
25,000
– – ﹤0.01% 3598
2025
Q3 		$87.5K Hold
25,000
– – ﹤0.01% 3772
2025
Q2 		$65K Hold
25,000
– – ﹤0.01% 3753
2025
Q1 		$47.5K Buy
+25,000
New +$66.5K ﹤0.01% 3620

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Walleye Trading's CMPX Position: Q2 2026 in Review

Walleye Trading held its Compass Therapeutics (CMPX) position steady in Q2 2026 at 25,000 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Walleye Trading first reported a position in CMPX in Q1 2025 and has held it in 6 quarters since. The position peaked at $134K in Q4 2025. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Walleye Trading held 25,000 shares of Compass Therapeutics worth $54.8K as of Q2 2026.
  • Walleye Trading left its Compass Therapeutics share count unchanged in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3569 holding.
  • Walleye Trading first reported a position in Compass Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Walleye Trading's Compass Therapeutics position peaked at $134K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.